US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist

3.290
+0.205+6.65%

Close May 9 16:00 ET

3.390
+0.100+3.04%

Post 19:56 ET

299.52MMarket Cap-8024P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

35.02%-6.38M

-158.71%-4.94M

-183.59%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

130.99%2.81M

-273.69%-6.56M

-2.73%-14.48M

Net income from continuing operations

85.54%-7.87M

34.33%-8.11M

83.77%-2.04M

64.47%-5.79M

161.03%8.07M

22.87%-54.41M

57.33%-12.35M

13.87%-12.54M

-31.82%-16.3M

9.90%-13.22M

Operating gains losses

--1.03M

----

Depreciation and amortization

-43.65%1.35M

17.88%468K

-55.87%263K

-56.67%289K

-55.30%325K

-19.47%2.39M

-45.69%397K

-19.02%596K

-10.11%667K

-3.71%727K

Other non cash items

-69.76%1.77M

3,492.59%1.83M

-96.05%88K

-97.25%52K

-111.49%-204K

-62.73%5.85M

-102.88%-54K

-53.74%2.23M

-56.35%1.89M

-61.83%1.78M

Change In working capital

-116.70%-5.34M

-105.58%-1.1M

-111.99%-1.44M

-162.24%-3.09M

106.05%283K

1,948.38%31.98M

612.10%19.71M

709.25%11.98M

30.22%4.96M

26.21%-4.68M

-Change in receivables

-141.80%-3.07M

-98.29%104K

-81.10%1.55M

-444.44%-2.51M

71.13%-2.22M

237.34%7.35M

343.92%6.1M

715.14%8.21M

136.12%729K

-127.56%-7.68M

-Change in inventory

43.26%-989K

-67.16%310K

34.25%-1.13M

372.03%1.03M

-103.21%-1.2M

-10.53%-1.74M

180.34%944K

-7,054.17%-1.72M

-847.50%-379K

-74.85%-591K

-Change in prepaid assets

-7.79%1.29M

110.25%73K

-77.61%-595K

-25.00%2.01M

15.22%-195K

11.21%1.4M

-33.08%-712K

54.67%-335K

-12.75%2.68M

57.01%-230K

-Change in payables and accrued expense

-4,677.03%-3.54M

90.09%-114K

-81.01%479K

-225.19%-2.92M

74.13%-978K

-119.42%-74K

-134.84%-1.15M

362.81%2.52M

147.51%2.33M

-30.24%-3.78M

-Change in other working capital

-96.14%966K

-110.13%-1.47M

-152.71%-1.74M

-73.00%-692K

-35.89%4.87M

603.26%25.04M

7,515.31%14.53M

203.39%3.31M

-121.54%-400K

838.52%7.6M

Cash from discontinued investing activities

Operating cash flow

35.02%-6.38M

-158.72%-4.94M

-183.55%-2.35M

-20.50%-7.91M

160.88%8.82M

70.23%-9.82M

204.40%8.42M

130.99%2.81M

-273.69%-6.56M

-2.73%-14.48M

Investing cash flow

Cash flow from continuing investing activities

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

-1,968.67%-1.72M

-248.97%-677K

-0.97%-104K

Capital expenditure reported

2.83%-995K

38.46%-16K

30.41%-151K

-22.01%-826K

98.08%-2K

-12.16%-1.02M

95.12%-26K

-161.45%-217K

-248.97%-677K

-0.97%-104K

Net intangibles purchase and sale

--0

----

---1.5M

--0

----

Cash from discontinued investing activities

Investing cash flow

60.58%-995K

38.46%-16K

91.21%-151K

-22.01%-826K

98.08%-2K

-176.45%-2.52M

95.12%-26K

-1,968.67%-1.72M

-248.97%-677K

-0.97%-104K

Financing cash flow

Cash flow from continuing financing activities

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

-102.27%-138K

17.41%10.2M

-86.88%1.3M

Net issuance payments of debt

-1,010.47%-22.49M

-390.81%-9.94M

51.41%1.02M

-564.30%-4.48M

---9.09M

---2.03M

--675K

---675K

--0

Net common stock issuance

-34.40%8.91M

-46.22%3.64M

-66.18%184K

-16.18%4.17M

-29.43%916K

-54.38%13.59M

30.38%6.76M

-91.06%544K

-42.19%4.98M

-86.88%1.3M

Proceeds from stock option exercised by employees

24,450.00%8.35M

99.56%-26K

120,100.00%4.8M

----

-90.09%34K

-2,292.88%-5.86M

---4K

----

Net other financing activities

306,833.33%9.2M

658.52%10.24M

---1.03M

--1.02M

---1.04M

78.57%-3K

135,100.00%1.35M

----

Cash from discontinued financing activities

Financing cash flow

-65.72%3.97M

1,572.22%3.91M

3,707.97%4.98M

-57.96%4.29M

-809.17%-9.21M

-61.50%11.59M

-95.71%234K

-102.27%-138K

17.41%10.2M

-86.88%1.3M

Net cash flow

Beginning cash position

-2.68%27.27M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

-11.89%28.02M

-40.16%18.65M

-48.31%17.7M

-46.41%14.74M

-11.89%28.02M

Current changes in cash

-352.86%-3.4M

-112.12%-1.05M

160.06%2.48M

-250.25%-4.45M

97.06%-391K

80.15%-751K

374.65%8.62M

131.07%954K

-56.07%2.96M

-208.38%-13.29M

End cash Position

-12.47%23.87M

33.61%24.92M

26.79%22.44M

82.42%26.88M

-2.68%27.27M

-40.16%18.65M

-48.31%17.7M

-46.41%14.74M

Free cash flow

40.25%-7.38M

-159.09%-4.96M

-328.75%-2.5M

-20.64%-8.73M

160.43%8.81M

63.58%-12.34M

197.63%8.39M

111.94%1.09M

-271.23%-7.24M

-2.72%-14.59M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	35.02%-6.38M	-158.71%-4.94M	-183.59%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M	130.99%2.81M	-273.69%-6.56M	-2.73%-14.48M
Net income from continuing operations	85.54%-7.87M	34.33%-8.11M	83.77%-2.04M	64.47%-5.79M	161.03%8.07M	22.87%-54.41M	57.33%-12.35M	13.87%-12.54M	-31.82%-16.3M	9.90%-13.22M
Operating gains losses	--1.03M	----	----	----	----	----	----	----	----	----
Depreciation and amortization	-43.65%1.35M	17.88%468K	-55.87%263K	-56.67%289K	-55.30%325K	-19.47%2.39M	-45.69%397K	-19.02%596K	-10.11%667K	-3.71%727K
Other non cash items	-69.76%1.77M	3,492.59%1.83M	-96.05%88K	-97.25%52K	-111.49%-204K	-62.73%5.85M	-102.88%-54K	-53.74%2.23M	-56.35%1.89M	-61.83%1.78M
Change In working capital	-116.70%-5.34M	-105.58%-1.1M	-111.99%-1.44M	-162.24%-3.09M	106.05%283K	1,948.38%31.98M	612.10%19.71M	709.25%11.98M	30.22%4.96M	26.21%-4.68M
-Change in receivables	-141.80%-3.07M	-98.29%104K	-81.10%1.55M	-444.44%-2.51M	71.13%-2.22M	237.34%7.35M	343.92%6.1M	715.14%8.21M	136.12%729K	-127.56%-7.68M
-Change in inventory	43.26%-989K	-67.16%310K	34.25%-1.13M	372.03%1.03M	-103.21%-1.2M	-10.53%-1.74M	180.34%944K	-7,054.17%-1.72M	-847.50%-379K	-74.85%-591K
-Change in prepaid assets	-7.79%1.29M	110.25%73K	-77.61%-595K	-25.00%2.01M	15.22%-195K	11.21%1.4M	-33.08%-712K	54.67%-335K	-12.75%2.68M	57.01%-230K
-Change in payables and accrued expense	-4,677.03%-3.54M	90.09%-114K	-81.01%479K	-225.19%-2.92M	74.13%-978K	-119.42%-74K	-134.84%-1.15M	362.81%2.52M	147.51%2.33M	-30.24%-3.78M
-Change in other working capital	-96.14%966K	-110.13%-1.47M	-152.71%-1.74M	-73.00%-692K	-35.89%4.87M	603.26%25.04M	7,515.31%14.53M	203.39%3.31M	-121.54%-400K	838.52%7.6M
Cash from discontinued investing activities
Operating cash flow	35.02%-6.38M	-158.72%-4.94M	-183.55%-2.35M	-20.50%-7.91M	160.88%8.82M	70.23%-9.82M	204.40%8.42M	130.99%2.81M	-273.69%-6.56M	-2.73%-14.48M
Investing cash flow
Cash flow from continuing investing activities	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K	-1,968.67%-1.72M	-248.97%-677K	-0.97%-104K
Capital expenditure reported	2.83%-995K	38.46%-16K	30.41%-151K	-22.01%-826K	98.08%-2K	-12.16%-1.02M	95.12%-26K	-161.45%-217K	-248.97%-677K	-0.97%-104K
Net intangibles purchase and sale	--0	--0	----	----	----	---1.5M	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	60.58%-995K	38.46%-16K	91.21%-151K	-22.01%-826K	98.08%-2K	-176.45%-2.52M	95.12%-26K	-1,968.67%-1.72M	-248.97%-677K	-0.97%-104K
Financing cash flow
Cash flow from continuing financing activities	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K	-102.27%-138K	17.41%10.2M	-86.88%1.3M
Net issuance payments of debt	-1,010.47%-22.49M	-390.81%-9.94M	51.41%1.02M	-564.30%-4.48M	---9.09M	---2.03M	---2.03M	--675K	---675K	--0
Net common stock issuance	-34.40%8.91M	-46.22%3.64M	-66.18%184K	-16.18%4.17M	-29.43%916K	-54.38%13.59M	30.38%6.76M	-91.06%544K	-42.19%4.98M	-86.88%1.3M
Proceeds from stock option exercised by employees	24,450.00%8.35M	99.56%-26K	120,100.00%4.8M	----	----	-90.09%34K	-2,292.88%-5.86M	---4K	----	----
Net other financing activities	306,833.33%9.2M	658.52%10.24M	---1.03M	--1.02M	---1.04M	78.57%-3K	135,100.00%1.35M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-65.72%3.97M	1,572.22%3.91M	3,707.97%4.98M	-57.96%4.29M	-809.17%-9.21M	-61.50%11.59M	-95.71%234K	-102.27%-138K	17.41%10.2M	-86.88%1.3M
Net cash flow
Beginning cash position	-2.68%27.27M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-11.89%28.02M	-40.16%18.65M	-48.31%17.7M	-46.41%14.74M	-11.89%28.02M
Current changes in cash	-352.86%-3.4M	-112.12%-1.05M	160.06%2.48M	-250.25%-4.45M	97.06%-391K	80.15%-751K	374.65%8.62M	131.07%954K	-56.07%2.96M	-208.38%-13.29M
End cash Position	-12.47%23.87M	-12.47%23.87M	33.61%24.92M	26.79%22.44M	82.42%26.88M	-2.68%27.27M	-2.68%27.27M	-40.16%18.65M	-48.31%17.7M	-46.41%14.74M
Free cash flow	40.25%-7.38M	-159.09%-4.96M	-328.75%-2.5M	-20.64%-8.73M	160.43%8.81M	63.58%-12.34M	197.63%8.39M	111.94%1.09M	-271.23%-7.24M	-2.72%-14.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall